SURATADENOTUREV
UNII FV0JG1SX76

Substance Identification & Data

This profile provides standardized clinical and technical data for Suratadenoturev, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FV0JG1SX76.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1268642-13-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FV0JG1SX76

CAS Registry Number

1268642-13-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SURATADENOTUREV

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C119617

National Cancer Institute reference terminology for clinical and research data.

INN ID

11484

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-80

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Suratadenoturev. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SURATADENOTUREV

Common Names & Synonyms

A RECOMBINANT REPLICATION-COMPETENT ADENOVIRUS TYPE 5 (AD-5) IN WHICH THE E1 GENE, INCLUDING ITS NORMAL TRANSCRIPTIONAL REGULATORY ELEMENT, HAS BEEN DELETED AND REPLACED BY AN EXPRESSION CASSETTE CONTAINING AN HTERT (HUMAN TELOMERASE REVERSE TRANSCRIPTASE) PROMOTER, THE AD E1A GENE, AN IRES (INTERNAL RIBOSOME ENTRY SITE) AND THE AD E1B GENE. E1A EXPRESSION IS CONTROLLED BY THE HTERT PROMOTER; E1B TRANSLATION IS EFFECTED BY THE IRES

A REPLICATION-COMPETENT ADENOVIRUS TYPE 5 IN WHICH THE E1A AND E1B GENES ARE UNDER THE CONTROL OF A HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) AND IRES, RESPECTIVELY.

DNA (RECOMBINANT HUMAN TELOMERASE-SPECIFIC REPLICATION-COMPETENT ONCOLYTIC ADENOVIRUS 5 VECTOR OBP-301)

SURATADENOTUREV [INN]

SURATADENOTUREV [USAN]

SURATADENOTUREV [WHO-DD]

TELOMELYSIN